Erasca, Inc. (ERAS)
14.02
+0.66
(+4.90%)
USD |
NASDAQ |
Jun 11, 16:00
14.02
0.00 (0.00%)
After-Hours: 18:46
Erasca Total Assets (Quarterly) : 461.23M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 461.23M |
| December 31, 2025 | 407.46M |
| September 30, 2025 | 420.40M |
| June 30, 2025 | 445.39M |
| March 31, 2025 | 471.24M |
| December 31, 2024 | 502.53M |
| September 30, 2024 | 528.90M |
| June 30, 2024 | 525.74M |
| March 31, 2024 | 370.02M |
| December 31, 2023 | 395.30M |
| September 30, 2023 | 419.41M |
| Date | Value |
|---|---|
| June 30, 2023 | 440.66M |
| March 31, 2023 | 467.54M |
| December 31, 2022 | 514.91M |
| September 30, 2022 | 446.43M |
| June 30, 2022 | 444.82M |
| March 31, 2022 | 475.47M |
| December 31, 2021 | 501.42M |
| September 30, 2021 | 521.95M |
| June 30, 2021 | 210.38M |
| March 31, 2021 | 224.63M |
| December 31, 2020 | 124.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.254B |
| Tango Therapeutics, Inc. | 435.79M |
| Kymera Therapeutics, Inc. | 1.669B |
| Bridgebio Oncology Therapeutics, Inc. | 417.65M |
| ImmunityBio, Inc. | 646.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 67.71M |
| Shareholders Equity (Quarterly) | 393.53M |
| Debt to Equity Ratio | 0.1168 |
| Current Ratio | 9.518 |
| Net Debt Paydown Yield | 0.02% |